Merit Financial Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Sell
5,520
-207
-4% -$18.1K ﹤0.01% 1529
2026
Q1
$518K Buy
5,727
+288
+5% +$26.4K ﹤0.01% 1359
2025
Q4
$489K Sell
5,439
-535
-9% -$50.7K ﹤0.01% 1319
2025
Q3
$588K Sell
5,974
-553
-8% -$54.8K 0.01% 1086
2025
Q2
$595K Buy
6,527
+2,836
+77% +$274K 0.01% 1019
2025
Q1
$418K Buy
3,691
+27
+0.7% +$2.89K 0.01% 1013
2024
Q4
$387K Sell
3,664
-1,494
-29% -$160K 0.01% 820
2024
Q3
$557K Sell
5,158
-957
-16% -$104K 0.01% 536
2024
Q2
$664K Sell
6,115
-1,048
-15% -$124K 0.01% 514
2024
Q1
$871K Buy
+7,163
New +$895K 0.02% 442

Other funds holding ZBH

Merit Financial Group's ZBH Position: Q2 2026 in Review

Merit Financial Group reduced its Zimmer Biomet (ZBH) stake by 3.6% in Q2 2026, selling an estimated $18.1K and leaving 5,520 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

Merit Financial Group first reported a position in ZBH in Q1 2024 and has held it in 10 quarters since. The position peaked at $871K in Q1 2024. 147 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Merit Financial Group held 5,520 shares of Zimmer Biomet worth $475K as of Q2 2026.
  • Merit Financial Group sold 207 Zimmer Biomet shares in Q2 2026, an estimated $18.1K.
  • Zimmer Biomet made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1529 holding.
  • Merit Financial Group first reported a position in Zimmer Biomet in Q1 2024 and has held it in 10 quarters since.
  • Merit Financial Group's Zimmer Biomet position peaked at $871K in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.